| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
i
|
|
|
|
Contents
|
|
iii-iv
|
|
| Review Article |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Pregnancy outcomes with an IUD in situ: a systematic review
17 August 2011
Abstract: Background: While intrauterine devices (IUDs) provide highly effective contraception, pregnancies among IUD users do rarely occur. The objective of this systematic review is to assess the ev...
|
Dalia Brahmi,
Maria W. Steenland,
Regina-Maria Renner,
Mary E. Gaffield,
Kathryn M. Curtis
et al.
|
131-139
|
|
| Commentary |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Feticidal digoxin injection before dilation and evacuation abortion: Evidence and ethics
27 May 2011
Feticidal injection of digoxin before dilation and evacuation (D&E) abortion has become common in recent years and is now a standard policy at some abortion clinics. The procedure entails amniocen...
|
David A. Grimes,
Gretchen S. Stuart,
Elizabeth G. Raymond
|
140-143
|
|
| Original Research Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation
11 July 2011
Abstract: Background: Digoxin is used to induce fetal demise before dilation and evacuation (D&E) abortion. Published data on the safety of digoxin in abortion care are limited. Study Design: We c...
|
Gillian Dean,
Lisa Colarossi,
Britt Lunde,
Adam R. Jacobs,
Lauren M. Porsch,
Maureen E. Paul
et al.
|
144-149
|
|
|
|
Infection and extramural delivery with use of digoxin as a feticidal agent
21 February 2011
Abstract: Background: Many abortion providers use digoxin to induce fetal demise prior to dilation and evacuation (D&E). Our primary objective was to examine the frequency of infection and extramu...
|
Rachel Steward,
Alexander Melamed,
Renita Kim,
Deborah Nucatola,
Mary Gatter
et al.
|
150-154
|
|
|
|
Revival of the intrauterine device: increased insertions among US women with employer-sponsored insurance, 2002–2008
01 August 2011
Abstract: Background: Use of the intrauterine device (IUD) in the United States has recently increased. New evidence for women with employer-sponsored health insurance permits analysis of variation an...
|
Xin Xu,
Maurizio Macaluso,
Lijing Ouyang,
Andrzej Kulczycki,
Scott D. Grosse
et al.
|
155-159
|
|
|
|
Does the provision of free intrauterine contraception reduce pregnancy rates among uninsured low-income women? A cohort study a two North Carolina clinics
15 July 2011
Abstract: Background: Low-income women are disproportionately affected by unintended pregnancy. The Access to Resources in Contraceptive Health Foundation was established to provide free levonorgestre...
|
Nicole Fanarjian,
Christina Drostin,
Joanne Garrett,
Arlin Montalvo
|
160-165
|
|
|
|
Access to contraception after health care reform in Massachusetts: a mixed-methods study investigating benefits and barriers
05 August 2011
Abstract: Background: In 2006, Massachusetts passed sweeping health care reform legislation aimed at improving access to health care for residents. This study investigates how this landmark legislatio...
|
Amanda Dennis,
Jill Clark,
Denisse Córdova,
Jennifer McIntosh,
Karen Edlund,
Britt Wahlin,
Lenore Tsikitas,
Kelly Blanchard
et al.
|
166-172
|
|
|
|
Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study
19 September 2011
Abstract: Background: We investigated the influence of an etonogestrel-releasing (ETG) implant and copper intrauterine device (IUD) on carbohydrate metabolism. Study Design: In this nonrandomized, ope...
|
Carolina L. Oderich,
Maria Celeste O. Wender,
Jaqueline N. Lubianca,
Letícia M. Santos,
Grasiele C. de Mello
et al.
|
173-176
|
|
|
|
Bioequivalence study of an oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium relative to ethinylestradiol/drospirenone and to levomefolate calcium alone
20 July 2011
Abstract: Background: A new tablet formulation containing 0.02 mg ethinylestradiol/3 mg drospirenone/0.451 mg levomefolate calcium (calcium salt containing 0.416 mg L-5-methyltetrahydrofolate) was ass...
|
Hartmut Blode,
Christine Klipping,
Frank Richard,
Dietmar Trummer,
Beate Rohde,
Konstanze Diefenbach
et al.
|
177-184
|
|
|
|
Induced abortion in Canada 1974–2005: trends over the first generation with legal access
05 August 2011
Abstract: Background: Canadian women currently entering menopause are the first generation with access to legal induced abortion throughout their reproductive years. Study Design: Statistics Canada da...
|
Wendy V. Norman
|
185-191
|
|
|
|
Can women accurately assess the outcome of medical abortion based on symptoms alone?
15 July 2011
Abstract: Background: The primary purpose of this study was to evaluate whether women undergoing medical abortion can accurately assess abortion outcome based on symptoms alone. Our secondary aim was ...
|
Andrea V. Jackson,
Ila Dayananda,
Jennifer M. Fortin,
Garrett Fitzmaurice,
Alisa B. Goldberg
et al.
|
192-197
|
|
|
|
Effect of shared contraceptive experiences on IUD use at an urban abortion clinic
17 August 2011
Abstract: Background: We studied the effect of contraceptive social networking on postabortion intrauterine device (IUD) uptake. This study explores whether women who have heard personal stories of IU...
|
Lyndsey S. Benson,
Alissa Perrucci,
Eleanor A. Drey,
Jody E. Steinauer
|
198-203
|
|
|
|
Analyzing the impacts of abortion clinic structures and processes: a qualitative analysis of women's negative experience of abortion clinics
11 August 2011
Abstract: Background: In the United States, the social myth that abortion clinics are unsafe, lonely places is pervasive. Little research has investigated the extent to which women's negative experien...
|
Katrina Kimport,
Kate Cockrill,
Tracy A. Weitz
|
204-210
|
|
|
|
Mifepristone may shorten the induction-to-abortion time for termination of second-trimester pregnancies by ethacridine lactate
15 July 2011
Abstract: Background: We reviewed our experience with adding mifepristone to the protocol for the termination of pregnancy up to 24 weeks of gestation by intra-amniotic ethacridine lactate. Study Desi...
|
YaLing Zhuang,
XiuYing Chen,
LiLi Huang
|
211-214
|
|
| Case Report |
| |
Article Title |
Author(s) |
Pages |
|
|
|
A life-threatening ectopic pregnancy with etonogestrel implant
15 September 2011
Abstract: Background: Etonogestrel contraceptive implant is a highly effective subdermal method of long-acting hormonal contraception for women. Case: We describe a case of ruptured ectopic pregnancy ...
|
Julie Bouquier,
Virginie Fulda,
Anne-Sophie Bats,
Fabrice Lécuru,
Cyrille Huchon
et al.
|
215-217
|
|
| Letters to the Editor |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Update on and correction to the cost effectiveness of contraceptives in the United States
16 August 2011
In , we update our results on the cost effectiveness of contraceptives in the United States to reflect recent increases in the average wholesale price (AWP) of the Mirena IUS to $844 (an increase of ...
|
James Trussell
|
218
|
|
|
|
Mifepristone+misoprostol vs. misoprostol alone for early medical abortion
01 August 2011
Ngoc et al. , in their double-blind randomized placebo-controlled trial, show that mifepristone+misoprostol is more efficacious than misoprostol-only for early medical abortion. The study was conducte...
|
Thoai D. Ngo,
Min Hae Park
|
219
|
|
|
|
Response to Letter to the Editor
05 August 2011
We thank Ngo and Park for their comments to our paper, “Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone” . We agree in principle that misoprostol is the o...
|
Jennifer Blum,
Nguyen Thi Nhu Ngoc,
Sheila Ragjavem,
Nguyen Thi Bach Nga,
Rasha Dabash,
Ayisha Diop,
Beverly Winikoff
et al.
|
219-220
|
|
